Clinical Trials Directory

Trials / Completed

CompletedNCT02423460

Threonine Requirement in IBD Adults and Healthy Adult Controls

Threonine Requirement in Healthy Adult Subjects and in Patients With Crohn's Disease and With Ulcerative Colitis Using the Indicator Amino Acid Oxidation (IAAO) Methodology

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
86 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The daily requirement of threonine, an essential amino acid, will be evaluated in healthy adult males and in adult males with Crohn's Disease or ulcerative colitis using the indicator amino acid oxidation (IAAO) method. Participants will consume specially formulated diets with varying levels of threonine.

Detailed description

Threonine is an essential amino acid which must be obtained from the diet. It is a component of mucin. Mucin, in turn, is a key protein in the mucous membrane that protects the lining of the intestine. Inflammatory bowel disease (IBD) is a group of inflammatory conditions that affect the colon and small intestine. IBD primarily includes ulcerative colitis (UC) and Crohn's disease (CD). In UC, the inflammation is usually in the colon whereas in CD inflammation may occur anywhere along the digestive tract. Studies in animals have shown that more threonine is used when there is inflammation in the intestine. The threonine requirement in healthy participants and in IBD patients will be determined using the indicator amino acid oxidation method. The requirement derived in healthy participants will be compared to that derived in patients with IBD. Each participant will take part in two x 3 day study periods. The first two days are called adaptation days where the subjects will consume a liquid diet specially designed for him. The diet will be consumed at home. It contains all vitamins, minerals, protein and all other nutrients required. On the third day, the participant will come to the Hospital for Sick Children in Toronto. Subjects will consume hourly meals for a total of 8 meals and a stable isotope 13C-phenylalanine. Breath and urine samples will be collected to measure the oxidation of phenylalanine from which the threonine requirement will be determined.

Conditions

Interventions

TypeNameDescription
OTHERThreonineThreonine will be fed at various intake levels ranging from high to low in order to determine its requirement in healthy males and in patients with Crohn's disease and Ulcerative colitis.

Timeline

Start date
2015-05-01
Primary completion
2018-09-17
Completion
2018-09-23
First posted
2015-04-22
Last updated
2018-11-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02423460. Inclusion in this directory is not an endorsement.